Good evening. This snapshot of stories and roundup is recommended just for you, based on your interests and reading history. | | | | Two national clinical trials of antiaging drugs for dogs are underway. (iStock) | | | | | | |  What to know Two national clinical trials are testing antiaging drugs rapamycin and LOY-002 in dogs. Rapamycin has shown promise in mice, but its effects on dogs and humans remain uncertain. Ethical concerns exist as pets can’t consent to trials. More research is needed to confirm safety and efficacy. Summary is AI-generated, newsroom-reviewed. | | | | | How was today's newsletter? | | | | | | | | |
Have a question? Ask the Post AI to learn more 
